mPATH is a cloud-based automation platform designed to improve preventive care by increasing cancer screening completion rates. The company targets health systems and insurers with a proven, peer-reviewed solution that supports breast, colorectal, and lung cancer detection, backed by clinical research and continuous learning. Headquartered in Winston-Salem, North Carolina, the platform emphasizes behavioral science, evidence-based engagement, and analytics to demonstrate ROI and ongoing innovation in cancer screening.
No recent deals for this company.